The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia
Open accessAbstract
In December 2019, a cluster of acute respiratory illness caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China.1, 2 Epidemiological and clinical characteristics, risk factors for mortality of patients infected with SARS-CoV-2, and risk factors in the susceptibility to SARS-CoV-2 included age and chronic disease have been reported.3-6 However, the use of biological markers to predict the susceptibility to SARS-CoV-2 has not been well described. So far, only one study has reported that ABO blood groups were associated with the susceptibility to SARS-CoV-2·7 In the present study, after eliminating other confounding risk factors (including age, gender and comorbidities), we further investigated and confirmed the association of ABO blood groups and risk of SARS-CoV-2 pneumonia in patients from the Central Hospital of Wuhan, as well as two hospitals in Wuhan, China. Patients diagnosed with SARS-CoV-2 who died or were discharged between February 1 and March 25, 2020, were included in this retrospective cohort study. The study was approved by the Ethics Committee of the Central Hospital of Wuhan, and the need for informed consent was waived.8 Epidemiological information, clinical data, underlying comorbidities, CT images of lungs, laboratory findings and clinical outcomes were extracted from electronic medical records. The blood group distribution data of the other two hospitals (Wuhan Jinyintan Hospital and Renmin Hospital of Wuhan University) and healthy controls in Wuhan came from the paper published online.7 Data were expressed as percentages (%). We used chi-squared tests or Fisher's exact tests in order to compare the various groups. The ABO blood group in 265 patients infected with SARS-CoV-2 from the Central Hospital of Wuhan showed a distribution of 39·3 %, 25·3 %, 9·8 % and 25·7 % for A, B, AB and O, respectively (Table I). The proportion of blood group A in patients infected with SARS-CoV-2 was significantly higher than that in healthy controls (39·3 % vs. 32·3 %, P = 0·017),7 while the proportion of blood group O in patients infected with SARS-CoV-2 was significantly lower than that in healthy controls (25·7 % vs. 33·8 %, P < 0·01). We next investigated whether age, gender and chronic disease influence the ABO blood group distribution (Table I). The results showed that, among blood group A (43·6 % vs. 32·2 % in controls, P < 0·01) and blood group O (22·2 % vs. 33·8 % in controls, P < 0·01), patients over 60 years of age were consistent with all the above patients. Similarly, we also found that A (42·5 % vs. 32·2 %, P = 0·021) and O (23·0 % vs. 33·8 %, P = 0·016) distribution of blood groups in male patients was consistent with all the above patients. In all chronic diseases, we found that the proportion of hypertension (41·7 % vs. 32·2 %, P = 0·031) and hepatitis (85·7 % vs. 32·2 %, P < 0·01) in blood group A was much higher than that in the control group; however, there is currently no literature supporting that hypertension and hepatitis increase the risk of infection of SARS-CoV-2. In dead patients, we found no differences between blood types. Finally, we integrated the data of the three hospitals in Wuhan for analysis (Table II).7 We still find that the proportion of blood group A in patients infected with SARS-CoV-2 was significantly higher than that in healthy controls (38·0 % vs. 32·2 %, P < 0·001), while the proportion of blood group O in SARS-CoV-2 infected patients was significantly lower than in healthy controls (25·7 % vs. 33·8 %, P < 0·001). The distribution ratio of blood type A and O between various ages and genders was almost consistent with the trend of all patients. In this study, we demonstrated that blood group A patients were at higher risk of hospitalization following SARS-CoV-2 infection, while blood group O patients had lower risk, which suggested that the ABO blood type could be used as a biomarker to predict the risk of SARS-CoV-2 infection. Coincidentally, previous studies found that ABO blood type distribution also had significant differences in other viral infections. Chen et al. reported that blood group O individuals were less likely to become infected by SARS coronavirus,9 Batool et al. found that blood group O might have some influence in protecting against blood-transmitted infection, and people having blood group A were more prone to contract hepatitis B and HIV.10 Jing et al. found that blood group B was associated with a lower risk of HBV infection.11 Guillon et al. reported that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by human natural anti-A antibodies, which might block the interaction between the virus and its receptor.12 This could explain why blood group A is susceptible, while blood group O is not. However, there may be other factors that need further study. In summary,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Guillon, P., Clément, M., Sébille, V., Rivain, J.-G., Chou, C.-F., Ruvoën-Clouet, N., & Le Pendu, J. (2008) · Glycobiology · doi:10.1093/glycob/cwn093 · Cited by 411
ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome
(2005) · JAMA · doi:10.1001/jama.293.12.1450-c · Cited by 350
Cited by
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
Nguyen, L., McCord, K. A., Bui, D. T., Bouwman, K. M., Kitova, E. N., Elaish, M., Kumawat, D., Daskhan, G. C., Tomris, I., Han, L., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-021-00924-1 · Cited by 259
COVID-19 versus HIT hypercoagulability
Warkentin, T. E., & Kaatz, S. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.017 · Cited by 57
Molecular genetics and genomics of the ABO blood group system
Yamamoto, F. (2021) · Annals of Blood · doi:10.21037/aob-20-71 · Cited by 30
Metadata
- Authors
- Li, J., Wang, X., Chen, J., Cai, Y., Deng, A., & Yang, M.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2020-05-26
- Volume
- 190
- Issue
- 1
- Pages
- 24-27
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W3022950647
- Cited by
- 370
- References
- 11
- FWCI
- 43.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.